Advances in Biomarkers for Detecting Early Cancer Treatment-Related Cardiac Dysfunction
With the gradual prolongation of the overall survival of cancer patients, the cardiovascular toxicity associated with oncology drug therapy and radiotherapy has attracted increasing attention. At present, the main methods to identify early cancer treatment-related cardiac dysfunction (CTRCD) include...
Saved in:
Main Authors: | Huiyu Xiao, Xiaojie Wang, Shuang Li, Ying Liu, Yijie Cui, Xiaoqin Deng |
---|---|
Format: | article |
Language: | EN |
Published: |
Frontiers Media S.A.
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/d8c62d5d835547c9919d7652bbbe34d0 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Assesment of the TEI index of myocardial performance in dogs with doxorubicin-induced cardiomiopathy
by: Sousa,MG, et al.
Published: (2014) -
Role of Cardiac Biomarkers in Cancer Patients
by: Gennaro Carmine Semeraro, et al.
Published: (2021) -
Immune Checkpoint Inhibitor Therapy Induces Inflammatory Activity in the Large Arteries of Lymphoma Patients under 50 Years of Age
by: Raffaella Calabretta, et al.
Published: (2021) -
Overweight as a Favorable Clinical Biomarker for Checkpoint Inhibitor Therapy Response in Recurrent Gynecologic Cancer Patients
by: Thomas Bartl, et al.
Published: (2021) -
Cardiac MRI in Immune Checkpoint Inhibitor Associated Pericarditis
by: Can Öztürk, et al.
Published: (2021)